BIBLIOGRAFIA
1) Martini N, Bains MS, Beattie EJ. Indications for pleurectomy in malignant effusion. Cancer 1975;35:734-738.
2) Van Ruth S, Baas P, Zoetmulder F. Surgical treatment of malignant Pleural Mesothelioma. Chest 2003 Feb;123:551-61.
3) Ruckdeschel JC. Management of malignant pleural effusion: an overview.
Semin Oncol 1988;15:24-28.
4) Lucchi M, Mussi A, Ambrogi M, Gunfiotti A, Fontanini G, Basolo F, Angeletti CA. Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol.
2001 Nov; 27:636-40.
5) Sugarbaker DJ, Garcia JP. Multimodality therapy for malignant pleural mesothelioma. Chest 1997; 112:272-5.
6) Rusch VW, Niedzwiecki D, Tao Y, et al. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy:pharmacokinetic studies.J Clin Oncol 1992;10:1001-6.
7) Rusch VW, Figlin R, Godwin D, Piantadosi S. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a lung cancer study group trial. J Clin Oncol 1991;9:313-319.
8) Van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002; 13:1173-84.
9) Cavaliere R, Ciogatto EC, Giovannelli BC et al. Selective heat sensitivity of cancer cells. J. Natl. Cancer Inst., 20: 1351-1387, 1967.
10) Hahn GM. Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res. 1974 Nov;34(11):3117-23.
11) Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia.Int J Hyperthermia. 1995 Jul- Aug;11(4):459-88.
12) Lin P. S., Ho K. C., Sung S. J., Gladding J. Effect of tumour necrosis factor, heat, and radiation on the viability and microfilament organization in cultured endothelial cells. Int. J. Hyperthermia, 8: 667-677, 1992.
13) Reinhold H. S., Endrich B. Tumour microcirculation as a target for hyperthermia. Int. J. Hyperthermia, 2: 111-137, 1986.
14) Song C. W., Rhee J. G., Levitt S. H. Blood flow in normal tissues and tumors during hyperthermia. J. Natl. Cancer Inst. (Bethesda), 64: 119-124, 1980.
15) Brown S. L., Hunt J. W., Hill R. P. Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia.
Int. J. Hyperthermia, 8: 501-514, 1992.
16) Fajardo L. F., Prionas S. D. Endothelial cells and hyperthermia. Int. J.
Hyperthermia, 10: 347-353, 1994.
17) Zaffaroni N, Villa R, Orlandi L, Vaglini M, Silvestrini R. Effect of hyperthermia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanoma.
Int J Hyperthermia. 1992 May-Jun;8(3):341-9.
18) Hahn GM, Strande DP. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J. Natl Cancer Inst., 57: 1063-1067, 1976.
19) Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiamineplatinum(II)-induced DNA damage in human esophageal cancer transplantable to nude mice.
Anticancer Res., 13: 1989-1997, 1980.
20) Kimura E, Howell SB. Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line. Cancer Chemother. Pharmacol., 32: 419-424, 1993.
21) Miller RC, Richards M, Baird C, Martin S, Hall EJ. Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential. Int. J. Hyperthermia, 10: 89-99, 1994.
22) Di Filippo F, Anza M, Rossi CR, et al. The application of hyperthermia in regional chemotherapy. Semin Surg Oncol 1998; 14:215-23.
23) Schraffordt Koops H, Eggermont AM, Lienard D, Kroon BB, et al.
Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas. Semin Surg Oncol 1998; 14:210-14.
24) Pestieau SR, Sugarbaker PH: Treatment of primary colon cancer with peritoneal carcinomatosis: Comparison of concomitant vs. Delayed management. Dis Colon Rectum 43:1341-1346,2000.
25) Gilly FN, Beaujard A, Glehen O, et al : Perinectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis : Phase I-II study. Anticancer Res 19:2317-2321, 1999.
26) Glehen O, Osinski D, Cotte E, et al: Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatmenet of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863-869, 2003.
27) Yellin A, Simansky DA, Paley M, Refaely Y. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Cancer 2001 Oct 15;92(8):2197-203.
28) Van Ruth S, van Tellingen O, Korse CM, Verwaal VJ, Zoetmulder FA.
Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma. Anticancer Drugs.
2003; 14: 57-65
29) De Bree E, van Ruth S, Baas P, et al: Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 2002; 121:480-7
30) Watanabe S, Sakasegawa K, Shimokawa S, Kariatsumari K, Nakam.
Sakata R. Intrapleural perfusion hyperthermo - chemotherapy under view assisted thoracoscopic surgery for malignant pleural disseminated case report. Anticancer Res. 2002 Nov-Dec;22(6B):3781-3.
31) Aderka D, Brown A, Zelikovski A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 1986; 57: 1846-1849.
32) Schmidt-Wolf IG, Rockstroh JK, Schuller H, et al: Malignant thymoma:
current status of classification and multimodality treatment. Ann Hematol 82:69-76, 2003
33) Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 77:1860-9, 2004
34) Lewis JE, Wick HR, Scheithauer BW, et al. Thymoma: a clinicopathologic review. Cancer 60:2727-43, 1987
35) Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 230:562-74, 1999
36) Venuta F, Anile M, Diso D, et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 37 (1): 13-25, 2010
37) Okumura M, Miyoshi S, Takeuchi Y, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 117: 605-13, 1999
38) Souadjian JV, Enriquez P, Silverstein MN, et al. The spectrum of diseases associated with thymoma. Arch Intern Med 134: 374-9, 1974
39) Barnes EW, Irvine WJ. Clinical syndromes associated with thymic disorders. Proc R Soc Med. 66: 151-4, 1973
40) Monden Y, et al: Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39:165, 1985.
41) LeBlanc J, Wood DE. Diagnosis of mediastinal tumors. In: Wood DE, Thomas CR, editors. Mediastinal tumors: update 1995, medical radiology.
Diagnostic imaging and radiation oncology volume. Heidelberg, Germany:
Springer – Verlang; 1995.p 1-10
42) Souza CA, Muller NL. Imaging of the mediastinum. In: Patterson GA, Cooper JD, Deslauriers J, et al editors. Pearson’s thoracic and oesophageal surgery, 3rd edition, Churchill Livingstone; 2008. P 1477-505
43) Jung KJ, Lee KS, Han J, et al. Malignant thymic epithelial tumors. Am J Roentgenol 176: 433-9, 2001.
44) Patterson GA: Thymomas. Semin Thorac Cardiovasc Surg 4:39, 1992
45) Rosai J., Levine G: Thumors of the Thymus. In Armed forces Institute of Pathology, Second Series, fascicle 13. Washington, DC, In Armed forces Institute of Pathology; 1976.
46) Müller-Hermelink HK, Marino M: Tymoma and Thymic carcinoma.
Relation of thymoma epithelial cells to the medullary differentiation of thymus. Virkows Arch A Pathol Anat Histopathol 407:119, 1985.
47) Lewis Je, Wick MR et al: Thymoma. A clinic pathologic review. Cancer 60: 2727,1987.
48) Rosai J, Sobin L: Histologic typing of tumours of the thymus. In International Histologic Classification of Tumours, ed 2. New York, Spinger,1999.
49) Kondo K, Yoshizawa K, Tsuyuguchi M, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77(4): 1183-8, 2004
50) Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-92, 1981
51) Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factor and long term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112: 376-84, 1996
52) Yu L, Zhang XJ, Ma S, Li F, Zhang YF. Thoracoscopic thymectomy for myasthenia gravis with and without thymoma: a single-center experience.
Ann Thorac Surg 93(1): 240-4. 2012
53) Toker A, Erus S, Ziyade S, Ozkan B, Tanju S. It is feasible to operate on pathological Masaoka stage I and II thymoma patients with video-assisted thoracoscopy: analysis of factors for a successful resection. Surg Endosc Dec 2012
54) Mussi A, Fanucchi O, Davini F, Lucchi M, Picchi A, Ambrogi MC, Melfi F. Robotic extended thymectomy for early-stage thymomas. Eur J Cardiothorac Surg 41(4): e43-6, 2012
55) Curran JrWJ, Kornstein MJ, Brooks JJ, Turrisi £rd AT. Invasive thymoma:
the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6: 1722-7, 1988
56) Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma. Cancer 94: 1405-13, 2002
57) Boston B. Chemotherapy of invasive thymoma. Cancer 38: 49-52, 1976
58) Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma: a 13 year experience. Cancer 68: 30-3, 1991
59) Hernandez-Ilizaliturri FJ, Tan D, Cipolla D, et al. Multimodality therapy for thymic carcinoma: result of a 30 year single institution experience. Am J Clin Oncol 27: 68-72, 2004
60) Rea F, et al: Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106:543, 1993.
61) Hima B. Kona, Vijay A. Rupanagudi, Ur Rehman Mohammed, Julian Williams, Padmanabhan Krishnan. Metastatic Pleural Thymoma 11 years after primary treatment with thymectomy. American College of Chest Physicians, 2007.
62) Lucchi M., Ambrogi M.C., Duranti L., Basolo F., Fontanini G., Angeletti C.A., Mussi A. Advanced stage Thymomas and Thymic Carcinomas:
Results of Multimodality Treatments. Ann. Thorac. Surg Ann. Thorac.
Surg. 2005;79:1840-4.
63) Lucchi M., Basolo F., Mussi A. Surgical treatment of pleural recurrence from thymoma. European Journal Of Thoracic Surgery 2008; 33:707-11.
64) Lucchi M, Viti A, Ricciardi R, Murri L, Mussi A. Four thymus-related syndromes in a case of invasive thymoma. J Thorac Caediovasc Surg. 134 (5): 1376-8, 2007
65) Rena O, Mineo TC, Casadio C. Multimodal treatment for stage IVA thymoma: a proposable strategy. Lung Cancer 76: 89-92, 2012
66) Yang HC, Yoon YS; Kim HK, et al. En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg 6: 1-5, 2011
67) Wright CD. Pleuro-pneumonectomy for the treatment for Masaoka stage IVA thymoma. Ann Thorac Surg 82 (4): 1234-9, 2006
68) Refaely Y, Simansky DA, Paley M, Gottfried M, Yellin A. Resection and perusion thermochemotherapy: a new approach for the treatmentr of thimic malignancies with pleural spread. Ann Thorac Surg 72 (2): 366-70, 2001
69) Ried M, Potzger T, Braune N, et al. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumors: perioperative management and clinical experience. Eur J Cardiothorac Surg. Aug 2012
70) Alexander HR Jr. Hyperthermia and its modern use in cancer treatment.
Cancer. 2003 Jul 15;98(2):277-82
71) Stehlin JS. Hyperthermic perfusion with chemotherapy for cancer of the extremities. Surg Gynecol Obstet 1969; 129:305-8.
72) Pilati P, Mocellin S, Rossi CR, Foletto M, Campana L, Nitti D, Lise M.
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol. 2003 Jun;10(5):484-5.
73) Beaujard AC, Glehen O, Caillot JL, Francois Y, Bienvenu J, Panteix G, Garbit F, Grandclément E, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer. 2000 Jun 1;88(11):2512-9
74) Bovolato et al. Intraoperative hyperthermic chemotherapy with cisplatin in the combined treatment of pleural mesothelioma: preliminary results.”
Eur. J. Oncol. – Vol.12 – N.3 – September 2007.
75) Yasunori Matsuzaki, Koichiro Shibata, et al. Intrapleral Perfusion Hyperthermo-Chemotherapy for Malignant Pleural Dissemination and Effusion. Ann Thorac Surg 1995;59:127-31.
76) Van Ruth S, Baas P, Haas RL, Rutgers EJ, Verwaal VJ, Zoetmulder F.
Cytoreductive surgery combined with intraoperative hyperthermal intrathoracic chemotherapy for stage I malignant pleural mesothelioma.
Ann Surg Oncol. 2003 Mar; 10(2):176-82.
77) Lencioni R, Cioni D, Bartolozzi C (2001) Percutaneous radiofrequency thermal ablation of liver malignancies: technique, indications, imaging findings and clinical results. Abdom Imaging 26: 345-360
78) Ambrogi MC, Lucchi M, Dini P, Melfi F, Fontanini G, Faviana P, Fanucchi O, Mussi A. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg. 2006 Jul;30(1):177-83. Epub 2006 May 24
79) Sawaji Y, Sato T, Takeuchi A, Hirata M, Ito A. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour- derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer. 2002 May 20;86(10):1597-603
80) Hildebrandt B., Wust P., Ahlers O., Dieing A., Sreenivasa G., Kerner T., Felix R. The cellular and molecular basis of hyperthermia. Critical Rev Oncol/Hematol 2002;43:33 – 56.
81) Atallah D, Marsaud V, Radanyi C, Kornprobst M, Rouzier R, Elias D, Renoir JM. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines. Int J Hyperthermia 2004; 20:405-19.
82) Van Ruth S, Verwaal VJ, Hart AAM, Van Slooten G.W., Zoetmulder FAN.
Heat penetration in Locally Hypertermia in the abdomen during Intra- operative Hyperthermic Intraperitoneal Chemotherapy. Anticancer Research 2003; 23:1501-508.
83) Ratto GB, Civalleri D, Esposito M, et al. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasability and pharmacokinetic study. J Torac. Cardiovas. Surg.
1999;177: 759-65.
84) Ichinose Y, Ohta M, YanoT, Yokoyama H, Asoh H, Hata K. Treatment of invasive thymoma with pleural dissemination. J Surg Oncol 1993; 54 (3):
180-3.
85) Kodama K, Doi O, Tatsuta M, Kuriyama K, Tateishi R. Development of postoperative intrathoracic chemo - thermothy for lung cancer with objective of improving local cure. Cancer. 1989 Oct 1;64(7):1422-8.
86) Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999 Dec; 6(8):790-6).
87) De Bree E, van Ruth S, Schotborgh CE, Baas P, Zoetmulder FA. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
Ann Surg Oncol. 2007 Oct;14(10):3019-26.
88) Takano YS, Harmon BV, Kerr JF. Apoptosis induced by mild hyperthermia in human and murine tumor cell lines: a study using electron microscopy and DNA gel electrophoresis. J Pathol 1991; 163: 329-36.
89) Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR et al. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006;24:1561–67.
90) Ruffini E, Mancuso M, Oliaro A, Casadio C et al. Recurrence of thymoma:
analysis of clinicopathologic features treatment, and outcome. J Thorac Cardiovasc Surg 1997 Jan; 113 (1): 55-63
91) Lucchi M, Davini F, Ricciardi R, Duranti L, et al. Management of pleural recurrence after curative resection of thymoma, J Thorac Cardiovasc Surg 2009 May; 137 (5): 1185-9
92) Hamaji M, Allen MS, Cassivi SD, et al. The role of surgical management in recurrent thymic tumors. Ann Thorac Surg 2012 Jul;94(1):247-54
